Vestal Point Capital’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98.3M | Buy |
2,975,000
+384,469
| +15% | +$12.7M | 5.18% | 3 |
|
|
2025
Q1 | $104M | Buy |
2,590,531
+240,531
| +10% | +$9.67M | 7.44% | 2 |
|
|
2024
Q4 | $111M | Buy |
2,350,000
+850,000
| +57% | +$40M | 6.55% | 2 |
|
|
2024
Q3 | $79.2M | Sell |
1,500,000
-575,000
| -28% | -$30.4M | 6.01% | 3 |
|
|
2024
Q2 | $112M | Sell |
2,075,000
-75,000
| -3% | -$4.06M | 8.38% | 2 |
|
|
2024
Q1 | $151M | Buy |
2,150,000
+2,100,000
| +4,200% | +$147M | 12.47% | 1 |
|
|
2023
Q4 | $4.17M | Buy |
+50,000
| New | +$4.17M | 0.44% | 34 |
|